MURPHY OIL CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MURPHY OIL CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,863	2,098	1,806	2,829	1,967	2,801	4,220	3,460	3,028	2,719
Cost of revenue					0	0	172	51.7	3.15	0
Gross profit					1,967	2,801	4,048	3,408	3,025	2,719
Selling, general and administrative	246	207	205	233	140	122	131	117	110	137
Operating income	-389	-26.3	216	445	-1,362	281	1,587	1,042	603	301
Interest expense	148	178	180	219	169	222	151	112	106	96.1
Other non-operating income	-104	-257	-173	-242	-187	-239	-136	-121	-35	-118
Pre-tax income	-493	-283	43	203	-1,549	42.9	1,450	921	568	183
Income tax	-219	270	-126	14.7	-294	-5.86	309	196	78.3	44.6
Income from continuing operations	-274	-553	169	189	-1,255	48.8	1,141	725	489	138
Net income to minority interests		0	8.39	104	-114	121	174	62.1	79.3	34.6
Net income	-276	-312	411	1,150	-1,149	-73.7	965	662	407	104
EBITDA	665	726	991	1,593	-375	1,077	2,364	1,904	1,468	1,279
EPS, basic	-1.60	-1.81	2.38	7.01	-7.48	-0.48	6.22	4.26	2.71	0.73
EPS, diluted	-1.60	-1.81	2.36	6.98	-7.48	-0.48	6.13	4.22	2.70	0.72
Shares, basic (weighted)	172	173	173	164	154	154	155	155	150	143
Shares, diluted (weighted)	172	173	174	165	154	154	157	157	151	144
Dividend per share	1.20	1.00	1.00	1.00	0.63	0.50	0.83	1.10	1.20	1.30

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	873	965	360	307	311	521	492	317	424	377
Receivables	357	243	232	427	262	258	391	344	273	347
Inventory	127	105	80	76.1	66.1	54.2	54.5	54.5	54.9	57.3
Other current assets	63.6	35.1	34.3	40.9	33.9	31.9	34.7	36.7	34.3	35.5
Total current assets	1,559	1,372	880	974	1,000	881	972	752	785	817
Property, plant and equipment	8,316	8,220	8,432	9,970	8,269	8,128	8,228	8,225	8,055	8,136
Lease right-of-use assets			0	598	928	881	946	745	778	805
Other non-current assets	54.6	57.8	49.4	46.9	28.6	29.3	44.3	43.7	50	74.1
Total assets	10,296	9,861	11,053	11,719	10,621	10,305	10,309	9,767	9,667	9,833
Accounts payable	785	596	348	602	407	623	544	447	472	572
Short-term debt	570	9.9	0.67	0	0	0.65	0.69	0.72	0.87	2.51
Total current liabilities	1,502	834	846	943	716	1,164	1,258	847	943	1,063
Long-term debt	2,423	2,907	3,109	2,803	2,988	2,465	1,822	1,328	1,275	1,383
Lease liabilities			0	521	845	761	743	552	537	538
Other non-current liabilities	617	632	624	613	681	571	305	310	274	264
Total liabilities	5,379	5,241	5,855	5,914	6,227	5,984	5,160	4,217	4,326	4,596
Total debt	2,776	2,773	2,776	2,803	2,788	2,461	1,818	1,325	1,270	1,272
Paid-in capital	917	918	980	949	942	927	894	880	849	860
Retained earnings	5,730	5,245	5,514	6,614	5,370	5,219	6,055	6,546	6,773	6,691
Treasury stock	-1,297	-1,276	-1,249	-1,717	-1,691	-1,655	-1,615	-1,738	-1,995	-2,073
Other comprehensive income	-628	-462	-610	-574	-601	-528	-535	-521	-628	-554
Shareholders' equity	4,917	4,620	4,829	5,467	4,214	4,157	4,995	5,363	5,194	5,118
Minority interests			368	337	180	163	154	187	148	118
Total equity	4,917	4,620	5,198	5,805	4,394	4,321	5,149	5,550	5,342	5,237
Total liabilities and equity	10,296	9,861	11,053	11,719	10,621	10,305	10,309	9,767	9,667	9,833
Shares outstanding	172	173	173	153	154	154	155	153	146	143

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-276	-312	419	1,253	-1,262	47.5	1,139	724	486	139
Depreciation and amortization	1,054	752	776	1,148	987	795	777	862	866	978
Stock-based compensation	46.3	40.4	34.5	50.2	24.8	43.7	74.6	58.8	40.8	50.1
Deferred income tax	-388	270	-178	28.5	-278	-4.15	286	180	72.4	34.7
Change in receivables	120	114	-30.2	-232	165	8.06	-137	47.2	71.1	-75.4
Change in inventory	-5.17	-15.5	16.8	10.3	5.95	12.8	-1.53	0.33	1.33	-1.46
Change in payables	-328	70.4	8.78	197	-209	95.2	69.9	-140	3.29	3.1
Cash from operations	601	613	749	1,489	803	1,422	2,180	1,749	1,729	1,248
Capital expenditures	-927	-910	-1,011	-1,344
Purchases of investments	-696	-213	0	0
Sales and maturities of investments	761	321	0	0
Cash from investing	286	-732	-1,805	-2,536	-859	-418	-1,109	-999	-908	-1,029
Debt issued							0	0	600	0
Share buybacks		0	0	-500	0	0	0	-150	-301	-103
Dividends paid	-207	-173	-173	-164	-96	-77.2	-128	-171	-180	-186
Cash from financing	-291	-188	144	-1,130	39.7	-795	-1,082	-924	-717	-264
Exchange rate effect	-6.39	1.33
Net change in cash	590	19.7	-271	-53.2	3.85	211	-29.2	-175	106	-46.4
Free cash flow	-326	-297	-262	145
Interest paid	128	144	158	180	192	166	150	109	78.8	88.1
Income taxes paid	6.71	5.97	7.6	6.65	44.2	-2.14	24.9	12.4	12.6	6.1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $36.33 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	18.6%	Operating income / revenue.
EBITDA margin	53.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	16.1%	Pre-tax income / revenue.
Net margin	9.8%	Net income / revenue.
Operating cash flow margin	52.1%	Cash from operations / revenue.
Effective tax rate	28.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	5.6%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.9%	Net income / average total assets.
Return on invested capital (ROIC)	6.3%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	4.8%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.7%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	34.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-10.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-13.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	6.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-10.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-12.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-50.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-42.5%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	-12.9%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-18.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-74.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-52.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	-73.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-51.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-27.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-17.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	9.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	8.3%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	16.4%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	15.8%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-1.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	0.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	1.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.85x	Current assets / current liabilities.
Quick ratio	0.77x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.40x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.29x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	15.1%	Total debt / total assets.
Liabilities / assets	47.4%	Total liabilities / total assets.
Net debt	$1.07B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.67x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	5.50x	Operating income / interest expense.
Working capital	-$175.5M	Current assets - current liabilities.
Tangible book value	$5.26B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.29x	Revenue / average total assets.
Fixed asset turnover	0.36x	Revenue / average property, plant and equipment.
Receivables turnover	6.79x	Revenue / average receivables.
Days sales outstanding	54 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.02	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$20.58	Revenue / diluted weighted shares.
Operating cash flow per share	$10.72	Cash from operations / diluted weighted shares.
Book value per share	$36.69	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$36.69	Tangible book value / shares outstanding.
Cash per share	$3.38	(Cash + short-term investments) / shares outstanding.
Payout ratio	65.7%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.21B	Share price x shares outstanding.
Enterprise value	$6.28B	Market cap + total debt - cash - short-term investments.
P/E	17.7x	Market cap / net income. Only when net income is positive.
P/S	1.73x	Market cap / revenue.
P/B	0.99x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	0.99x	Market cap / tangible book value, when positive.
P/OCF	3.33x	Market cap / cash from operations, when positive.
EV/Sales	2.09x	Enterprise value / revenue.
EV/EBIT	11.2x	Enterprise value / operating income, when both are positive.
EV/EBITDA	3.93x	Enterprise value / EBITDA, when both are positive.
Earnings yield	5.6%	Net income / market cap (the inverse of P/E).
Dividend yield	3.7%	Dividends paid over the period / market cap.
Shareholder yield	3.7%	(Dividends paid + share buybacks) / market cap.

What was MURPHY OIL CORP's revenue in fiscal 2025?

MURPHY OIL CORP reported revenue of $2.72B for fiscal 2025, 10.2% lower than the year before.

Was MURPHY OIL CORP profitable in fiscal 2025?

Yes. Net income was $104.2M, a net margin of 3.8%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MURPHY OIL CORP